CUL7 maps to the 6p21.1 amplicon characteristic of this type of liver cancer, suggesting that this particular cancer is driven by the anti-apoptotic effect of increased CUL7 through p53 downregulation (Paradis et al., 2013). This evidence concerns the gene TP53 and cancer.